Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $184.42 USD
Change Today +0.56 / 0.30%
Volume 804.4K
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:12 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - alexion pharmaceuticals inc (ALXN)

NameBoard RelationshipsTitleAge
David L. Hallal 10 RelationshipsChief Executive Officer and Director49
Leonard Bell M.D.10 RelationshipsCo-Founder, Chairman of The Board and Consultant57
Joseph A. Madri Ph.D., M.D.No RelationshipsCo-Founder68
Vikas Sinha M.B.A., C.A., CPANo RelationshipsChief Financial Officer and Executive Vice President52
Frank J. Wright No RelationshipsSenior Vice President and President of Alexion Pharma International Sàrl67

Board Members - alexion pharmaceuticals inc (ALXN)

NameBoard RelationshipsPrimary CompanyAge
Leonard Bell M.D.10 RelationshipsAlexion Pharmaceuticals, Inc.57
David L. Hallal 10 RelationshipsAlexion Pharmaceuticals, Inc.49
R. Douglas Norby 48 RelationshipsMagnaChip Semiconductor Corporation79
Alvin S. Parven 10 RelationshipsAlexion Pharmaceuticals, Inc.75
Andreas Rummelt Ph.D.24 RelationshipsInterPharmaLink AG59

Executive Committees* - alexion pharmaceuticals inc (ALXN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeR. Douglas Norby 48 Relationships4 Executives
Compensation CommitteeAlvin S. Parven 10 Relationships3 Executives
Nominating CommitteeAnn M. Veneman J.D. 52 Relationships4 Executives
Corporate Governance CommitteeAnn M. Veneman J.D. 52 Relationships4 Executives
Finance CommitteeR. Douglas Norby 48 Relationships4 Executives
View ALXN Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $184.35 USD +0.49

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Croda International PLC 2,768 GBp -10.00
Dr Reddy's Laboratories Ltd 3,548 INR -25.90
Sigma-Aldrich Corp $139.48 USD +0.04
Symrise AG €55.85 EUR -0.241
United Therapeutics Corp $169.34 USD -3.59
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 61.9x
Price/Sales 15.9x
Price/Book 10.3x
Price/Cash Flow 69.3x
TEV/Sales 17.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.